Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)

Fig. 1

Study scheme. Patients are stratified into three functional groups by comprehensive geriatric assessment and receive different intensity treatments. After the first cycle, CGA is repeated and patients are attributed to their definitive treatment groups. The primary end point (decrease of five points or less in Barthels ADL) is assessed by the second CGA

Back to article page
\